Oncology Institute Q4 Earnings Call Highlights [Yahoo! Finance]
The Oncology Institute, Inc. (TOI)
Company Research
Source: Yahoo! Finance
41.6% YoY) and 2025 revenue exceeded $500 million (~28% growth), with adjusted EBITDA of $147,000, $33.6 million cash at year-end and $24 million of convertible preferred note reduction. Delegated capitation is driving growth: The Elevance Florida partnership (about 70,000 lives) is ramping and expected to more than double in 2026, and delegated members—while 2026 outlook and margin trajectory: Management reaffirmed plans for full-year positive adjusted EBITDA in 2026 with guidance of $630–650 million revenue and $0–9 million adjusted EBITDA, expecting modest gross-margin improvement and only a minimal IRA impact (less than 1% on IMBRUVICA economics). Interested in The Oncology Institute, Inc.? Here are five stocks we like better. The Oncology Institute (NASDAQ:TOI) reported fourth-quarter and full-year 2025 results highlighted by what management described as its first profitable quarter as a public company on an adjusted EBITDA basis, alongside continued growth in its capita
Show less
Read more
Impact Snapshot
Event Time:
TOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOI alerts
High impacting The Oncology Institute, Inc. news events
Weekly update
A roundup of the hottest topics
TOI
News
- Oncology Institute (TOI) had its price target raised by B. Riley Financial, Inc. from $6.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... [Yahoo! Finance]Yahoo! Finance
- The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026GlobeNewswire
- Oncology Institute (TOI) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $5.00 price target on the stock.MarketBeat
- Oncology Institute (TOI) had its "buy" rating reaffirmed by BTIG Research. They now have a $7.00 price target on the stock.MarketBeat
TOI
Earnings
- 3/12/26 - Beat
TOI
Sec Filings
- 3/20/26 - Form 3
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- TOI's page on the SEC website